BR0314709A - Derivados de pirazol - Google Patents

Derivados de pirazol

Info

Publication number
BR0314709A
BR0314709A BR0314709-6A BR0314709A BR0314709A BR 0314709 A BR0314709 A BR 0314709A BR 0314709 A BR0314709 A BR 0314709A BR 0314709 A BR0314709 A BR 0314709A
Authority
BR
Brazil
Prior art keywords
derivatives
compounds
preparation
reverse transcriptase
present
Prior art date
Application number
BR0314709-6A
Other languages
English (en)
Inventor
Oscar Barba
Lyn Howard Jones
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0222374A external-priority patent/GB0222374D0/en
Priority claimed from GB0223356A external-priority patent/GB0223356D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of BR0314709A publication Critical patent/BR0314709A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"DERIVADOS DE PIRAZOL". Esta invenção relaciona-se com derivados de pirazol de fórmula ou seus sais, solvatos ou derivados farmaceuticamente aceitáveis, em que R^ 1^ a R^ 4^ são definidos na descrição, e com processos para a sua preparação, intermediários utilizados na sua preparação, composições que os contenham e as utilizações de tais derivados. Os compostos da presente invenção ligam-se à enzima transcriptase reversa e são seus moduladores, especialmente inibidores. Como tal os compostos da presente invenção são úteis no tratamento de uma variedade de perturbações incluindo aquelas nas quais a inibição da transcriptase reversa está implicada. As perturbações com interesse incluem as causadas pelo Vírus da Imunodeficiência Humana (HIV) e as retroviroses geneticamente relacionadas, tais como a Síndrome da Imunodeficiência Adquirida (AIDS).
BR0314709-6A 2002-09-26 2003-09-15 Derivados de pirazol BR0314709A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0222374A GB0222374D0 (en) 2002-09-26 2002-09-26 Chemical compounds
GB0223356A GB0223356D0 (en) 2002-10-08 2002-10-08 Chemical compounds
PCT/IB2003/004158 WO2004029042A1 (en) 2002-09-26 2003-09-15 Pyrazole derivatives as reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
BR0314709A true BR0314709A (pt) 2005-07-26

Family

ID=32044462

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314709-6A BR0314709A (pt) 2002-09-26 2003-09-15 Derivados de pirazol

Country Status (7)

Country Link
EP (1) EP1546132A1 (pt)
JP (1) JP2006504803A (pt)
AU (1) AU2003260908A1 (pt)
BR (1) BR0314709A (pt)
CA (1) CA2497333A1 (pt)
MX (1) MXPA05003195A (pt)
WO (1) WO2004029042A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602007013573D1 (de) 2006-08-16 2011-05-12 Hoffmann La Roche Nicht-nukleosidische reverse-transkriptase-hemmer
CN101784529A (zh) 2007-06-22 2010-07-21 弗·哈夫曼-拉罗切有限公司 作为非核苷逆转录酶抑制剂的脲和氨基甲酸酯衍生物
MX2010006397A (es) 2007-12-21 2010-07-05 Hoffmann La Roche Compuestos heterociclicos antivirales.
JO3637B1 (ar) 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗ｒｓｖ活性之吡唑并嘧啶
KR20200116099A (ko) 2018-01-31 2020-10-08 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 Rsv에 대한 활성을 갖는 시클로알킬 치환 피라졸로피리미딘
EP3784667B1 (en) 2018-04-23 2023-08-16 Janssen Sciences Ireland Unlimited Company Heteroaromatic compounds having activity against rsv

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3419391A (en) * 1965-05-24 1968-12-31 Eastman Kodak Co Silver halide color photography utilizing magenta-dye-forming couplers
DK169672B1 (da) * 1985-05-20 1995-01-09 Mitsubishi Chem Ind Farmaceutiske præparater indeholdende pyrazolonderivater som aktiv bestanddel og anvendelsen af pyrazolonderivater til fremstilling af farmaceutiske præparater
JPH0667838B2 (ja) * 1985-12-25 1994-08-31 三菱化成株式会社 過酸化脂質生成抑制剤
JPH01125379A (ja) * 1987-11-10 1989-05-17 Sumitomo Chem Co Ltd 置換ピラゾール誘導体、その製造方法およびそれを有効成分とする農園芸用殺菌剤
JPH03500542A (ja) * 1988-05-09 1991-02-07 ビーチャム　グループ　ピーエルシー 新規な化合物及び治療法
JPH03141276A (ja) * 1989-10-24 1991-06-17 Nissan Chem Ind Ltd 置換ピラゾール誘導体および農園芸用殺菌剤
US5189040A (en) * 1990-05-28 1993-02-23 Sumitomo Chemical Company, Limited Pyrazole derivatives, method for producing the same and agricultural and/or horticultural fungicides containing the same as active ingredient
US5447831A (en) * 1993-10-19 1995-09-05 Eastman Kodak Company Photographic element employing hue correction couplers
US6365334B1 (en) * 1993-10-22 2002-04-02 Eastman Kodak Company Photographic elements containing aryloxypyrazolone couplers and sulfur containing stabilizers
GB0024795D0 (en) * 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases

Also Published As

Publication number Publication date
WO2004029042A1 (en) 2004-04-08
MXPA05003195A (es) 2005-06-08
JP2006504803A (ja) 2006-02-09
AU2003260908A1 (en) 2004-04-19
EP1546132A1 (en) 2005-06-29
CA2497333A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
BR0208811A (pt) Derivados de pirazol para tratamento de hiv
BRPI0413469A (pt) derivados de piperazina para o tratamento de infecções por hiv
BR9808513A (pt) Composto, composição farmacêutica, método para tratamento de infecções por hiv e kit farmacêutico.
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
BRPI0513717A (pt) derivados de piridina
BRPI0408767B8 (pt) inlbidores da transcriptase reversa não-nucleosídeos para tratamento de doenças mediadas pelo hiv, seu uso, e composição farmacêutica
BR0112252A (pt) Derivados de pirazole
BRPI0408704A (pt) benzil-piridazinonas como inibidores de transcriptase reversa
HUP0203122A2 (hu) Fab I inhibitorok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
BR0108456A (pt) Composto, uso de um composto, métodos de tratamento ou de profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e de doenças humanas, e ,processo para preparação de um composto
BR0015056A (pt) Composto, uso de um composto, composição farmacêutica, método de tratamento de infecções por hiv e kit farmacêutico
BRPI0407591A (pt) inibidores de transcriptase reversa de não-nucleosìdeo
BR0309748A (pt) Derivados de n-acil piperidina e composição compreendendo os mesmos
BR0314860A (pt) Derivados de pirazol
BR0314709A (pt) Derivados de pirazol
BR0306927A (pt) Compostos tricìclicos de 2-pirimidona úteis como inibidores de transcriptase reversa de hiv
BR0015333A (pt) Derivados de isoxazol como inibidores de fosfodiesterase vii
BRPI0509853A (pt) compostos de imidazol ligados a enxofre para o tratamento de hiv
BR0308807A (pt) Compostos tiazol-2-il-imina como inibidores de pde-7
BR0314759A (pt) Derivados de pirazol
BR0314243A (pt) Derivados de 4-(3,5-dicianofenoxi)pirazolo para uso como moduladores da transcriptase reversa no tratamento da i.a hiv
BR0113752A (pt) Derivados piperidina para uso inibidores 2,3-óxido esqualeno lanoesterol ciclase
DE60321700D1 (de) Pyrazolderivate und deren verwendung als therapeutische mittel für durch hiv vermittelte krankheiten
AP1846A (en) Pyrazole Derivatives.
BR0315713A (pt) Composto, processo para a preparação do composto, composição farmacêutica, métodos para reduzir a glicose, para a prevenção ou para o tratamento de doenças e uso do composto

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.